Higher levels of SERPINA1 has been associated with chemoresistance of human epithelial ovarian cancer [72] and breast cancer [73] and has also been proposed as a potential serum biomarker for GC [74]. This evidence concerns the gene SERPINA1 and breast carcinoma.